Replies to post #136942 on Biotech Values

[DewDiligence]

I disagree.

p.s. I edited my post to reply to the separate issue you raised on the pipeline, which I consider extraneous to the question at hand.

[mcbio]

If MNTA isn't going to be profitable for most of these 10 years then I'd look elsewhere for an investment.

And who is to say MNTA won't be profitable for most of these 10 years? mC alone would presumably drive MNTA to profitability. The prospect of mC on the market is not some distant event. (Obviously there's no guarantee mC will ever reach the market but the potential can't be ignored.) And is it really a stretch to think that MNTA/BAX won't have at least one FoB on the market in 4 or 5 years. I would think a single FoB, ignoring the multiple FoBs MNTA/BAX are working on, would also be sufficient to drive MNTA to profitability.